Mesalamine - NDC Database (Page 4)
68382-435 Aug 02, 2018
Mesalamine 800 mg Oral Tablet, Delayed Release by Zydus Pharmaceuticals (Usa) Inc.
Mesalamine 800 mg Oral Tablet, Delayed Release by Zydus Pharmaceuticals (Usa) Inc.
68382-452 Aug 13, 2021
Mesalamine .375 g/1 Oral Capsule, Extended Release by Zydus Pharmaceuticals (Usa) Inc.
Mesalamine .375 g/1 Oral Capsule, Extended Release by Zydus Pharmaceuticals (Usa) Inc.
68682-113 Jul 19, 2018
Mesalamine 375 mg Oral Capsule, Extended Release by Oceanside Pharmaceuticals
Mesalamine 375 mg Oral Capsule, Extended Release by Oceanside Pharmaceuticals
69918-560 Jun 24, 2019
Mesalamine Rectal Rectal 1000 mg Rectal Suppository by Amring Pharmaceuticals Inc.
Mesalamine Rectal Rectal 1000 mg Rectal Suppository by Amring Pharmaceuticals Inc.
70710-1543 Jan 17, 2019
Zaldyon 800 mg Oral Tablet, Delayed Release by Zydus Pharmaceuticals (Usa) Inc.
Zaldyon 800 mg Oral Tablet, Delayed Release by Zydus Pharmaceuticals (Usa) Inc.
70748-214 May 18, 2020
Mesalamine 375 mg Oral Capsule, Extended Release by Lupin Pharmaceuticals, Inc.
Mesalamine 375 mg Oral Capsule, Extended Release by Lupin Pharmaceuticals, Inc.
70771-1625 Aug 13, 2021
Mesalamine .375 g/1 Oral Capsule, Extended Release by Cadila Healthcare Limited
Mesalamine .375 g/1 Oral Capsule, Extended Release by Cadila Healthcare Limited
75929-137 Jul 19, 2018
Mesalamine 375 mg Oral Capsule, Extended Release by Pharma Packaging Solutions, LLC Dba Tjoapack LLC
Mesalamine 375 mg Oral Capsule, Extended Release by Pharma Packaging Solutions, LLC Dba Tjoapack LLC
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.